Olema Pharmaceuticals Inc (OLMA)
NASDAQ
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -23.22M | -27.22M | -29.6M | -21.6M | -23.34M | -30.42M | -34.34M | -33.53M |
Pre Tax Income | -22.72M | -26.18M | -28.29M | -20.1M | -21.5M | -26.77M | -30.97M | -30.38M |
Net Income | -22.72M | -26.18M | -28.29M | -20.1M | -21.5M | -26.77M | -30.97M | -30.38M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -23.32M | -27.15M | -29.59M | -21.65M | -23.42M | -30.32M | -34.32M | -33.49M |
EBITDA | -23.13M | -27.12M | -29.5M | -21.5M | -23.25M | -30.33M | -34.25M | -33.44M |
Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -2.08M | -4.32M | -21.53M | -71.49M | -106.99M | -104.96M |
Pre Tax Income | -2.2M | -4.32M | -22.12M | -71.1M | -104.79M | -96.66M |
Net Income | -2.2M | -4.32M | -23.99M | -71.1M | -104.79M | -96.66M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.847 | -1.664 | -0.61 | -1.786 | -2.601 | -1.765 |
EBIT | -2.17M | -4.32M | -21.53M | -71.54M | -107.02M | -104.98M |
EBITDA | -2.07M | -4.31M | -21.52M | -71.33M | -106.63M | -104.58M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.